VIDEO: Chondroitin tops celecoxib in reducing knee OA structural progression

SAN FRANCISCO – Patients with symptomatic knee osteoarthritis who received pharmaceutical-grade chondroitin sulfate for 2 years lost about 20% less cartilage volume than did patients treated with...

Field of Interest: Rheumatology